Disubstituted phthalazine Hedgehog pathway antagonists

Details for Australian Patent Application No. 2009320251 (hide)

Owner Eli Lilly and Company

Inventors Bastian, Jolie Anne; Hipskind, Philip Arthur; Sall, Daniel Jon; Wilson, Takako

Agent Spruson & Ferguson

Pub. Number AU-A-2009320251

PCT Pub. Number WO2010/062507

Priority 61/110,703 03.11.08 US

Filing date 22 October 2009

Wipo publication date 3 June 2010

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/062507 Priority application(s): WO2010/062507

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009320254-Multi-circuit electrified ceiling grid

2009320250-Decahydro-1H-indenoquinolinone and decahydro3H-cyclopentaphenanthridinone CYP17 inhibitors